½ÃÀ庸°í¼­
»óǰÄÚµå
1381674

¼¼°èÀÇ °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Kyphoplasty Market Size study & Forecast, by Product by Application, by Indication, by End-use and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀåÀº 2022³â ¾à 6¾ï 3,330¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2023-2030³â µ¿¾È 5.3% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼úÀº ôÃß »À(ôÃßü)¿¡ °ñÀýÀÌ ¹ß»ýÇÏ¿© ¿µÇâÀ» ¹ÞÀº ôÃß°¡ ¾²·¯Áö°Å³ª ³ôÀ̸¦ ÀҴ ôÃ߾йڰñÀýÀ» Ä¡·áÇÏ´Â ÀÇ·á ½Ã¼úÀÔ´Ï´Ù. ÀÌ·¯ÇÑ °ñÀýÀº °ñ´Ù°øÁõ, ôÃß Á¾¾ç, ¿Ü»ó µîÀÇ ÁúȯÀ¸·Î ÀÎÇØ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼úÀº ÁַΠôÃß ¾Ð¹Ú °ñÀý·Î ÀÎÇÑ ÅëÁõÀ» ¿ÏÈ­Çϰí ôÃ߸¦ ¾ÈÁ¤½Ã۰í ȯÀÚÀÇ À̵¿¼º°ú »îÀÇ ÁúÀ» Çâ»ó½Ã۱â À§ÇØ ½ÃÇàµË´Ï´Ù. Àü ¼¼°è °ñ´Ù°øÁõ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

Frontiers in Endocrinology Àú³Î¿¡ 2022³â 5¿ù °ÔÀçµÈ ¿¬±¸¿¡ µû¸£¸é, Àü ¼¼°è 2¾ï ¸íÀÇ ¿©¼ºÀÌ °ñ´Ù°øÁõÀ» ¾Î°í ÀÖ´Â °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. 2050³â±îÁö Àü ¼¼°èÀûÀ¸·Î ¿©¼ºÀº 240%, ³²¼ºÀº 310%±îÁö °í°üÀý °ñÀý ¹ß»ý·üÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¿¬±¸¿¡ µû¸£¸é, ÀÌ¹Ì ÇÑ ¹øÀÇ °ñÀýÀÌ ÀÖ´Â ¼ºÀÎÀº °ñÀý À¯Çü¿¡ °ü°è¾øÀÌ ´Ù¸¥ À¯ÇüÀÇ °ñÀýÀÌ ¹ß»ýÇÒ È®·üÀÌ 50%-100% ´õ ³ôÀ¸¸ç, °ñ¹Ðµµ°¡ ³·Àº ȯÀÚ¿¡¼­´Â °ÅÀÇ ¸ðµç À¯ÇüÀÇ °ñÀýÀÌ Áõ°¡ÇÑ´Ù°í ÇÕ´Ï´Ù. ÀÌ´Â °ñ´Ù°øÁõÀÇ °¡Àå ½É°¢ÇÑ °á°ú´Â °ñÀýÀ̸ç, °ñ´Ù°øÁõ ÀÌȯÀ²ÀÇ Áõ°¡´Â °á±¹ ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡ÇÒ °ÍÀÓÀ» º¸¿©ÁÝ´Ï´Ù. ¶ÇÇÑ À¯¿£ °æÁ¦»çȸ±¹ÀÇ Á¶»ç¿¡ µû¸£¸é 2022³â¿¡´Â Àü ¼¼°èÀûÀ¸·Î 7¾ï 7,100¸¸ ¸íÀÌ 65¼¼ ÀÌ»óÀÌ µÉ °ÍÀ̸ç, 2030³â¿¡´Â ³ëÀÎ Àα¸°¡ 9¾ï 9,400¸¸ ¸í, 2050³â¿¡´Â 16¾ï ¸íÀ¸·Î ´Ã¾î³¯ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù. µû¶ó¼­ °í·ÉÀÚÀÇ ³ëÈ­¿¡ µû¸¥ °ñ·® °¨¼Ò·Î ÀÎÇØ ³ëÀÎ Àα¸ÀÇ È®´ë¿Í ÇÔ²² °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼úÀÇ Çʿ伺ÀÌ ³ô¾ÆÁú °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ, ±â¼ú ¹ßÀü°ú ÀÇ·áºñ Áõ°¡´Â ½ÃÀå¿¡ »õ·Î¿î ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿Í ´ëü Ä¡·áÀÇ °¡¿ë¼ºÀº 2023-2030³â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

°æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ÁÖ¿ä ½ÃÀå ÁøÀÔ ±â¾÷ÀÇ Á¸Àç, Áúº´ À¯º´·ü Áõ°¡, Á¤ºÎÀÇ À¯¸®ÇÑ »óȯ Á¤Ã¥ Áõ°¡, ÀÌ Áö¿ªÀÇ ½ÅÁ¦Ç° °³¹ß ¹× ÀÇ·áºñ Áõ°¡·Î ÀÎÇØ 2022³â ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ¹Ý¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ëÀÎ Àα¸ Áõ°¡, ´Ù¾çÇÑ Áúº´ÀÇ À¯º´·ü Áõ°¡, ÆÄÆ®³Ê½Ê Áõ°¡, Á¦Ç° °³¹ß Ȱµ¿ Áõ°¡, ÀÌ Áö¿ªÀÇ ÀÇ·á ÁöÃâ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ °¡Àå ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû, ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï »óȲ°ú Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚµéÀÌ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • »ê¾÷ÀÇ ÁøÈ­
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó ¿¬µµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå ¿ªÇÐ

  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀåÀÇ ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
      • °ñ´Ù°øÁõ Áõ°¡
      • °í·ÉÀÚ Àα¸ Áõ°¡
    • ½ÃÀå °úÁ¦
      • ¾ö°ÝÇÑ ±ÔÁ¦ ü°è
      • ´ëü Ä¡·á ÀÌ¿ë °¡´É¼º
    • ½ÃÀå ±âȸ
      • ±â¼ú Áøº¸
      • ÀÇ·áºñ Áõ°¡

Á¦4Àå ¼¼°èÀÇ °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's 5 Force ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷ °£ÀÇ °æÀï °ü°è
  • Porter's 5 Force ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19 ¿µÇ⠺м®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °üÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð°ú Á¦¾È

Á¦5Àå °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå : Á¦Ç°º°

  • ½ÃÀå ÇöȲ
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå : Á¦Ç°º°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå, Á¦Ç°º°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • dz¼± Ä«Å×ÅÍ
    • »À ¾×¼¼½º µð¹ÙÀ̽º
    • ½Ã¸àÆ® ÀÀ¿ë Á¦Ç°
    • »À ½Ã¸àÆ®
    • ½Ã¸àÆ® È¥ÇÕ ½Ã½ºÅÛ
    • ±â±¸

Á¦6Àå °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå : ¿ëµµº°

  • ½ÃÀå ÇöȲ
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå : ¿ëµµº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå, ¿ëµµº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • Ãß°ñ Á¶Àý ȸº¹
    • ôÃß °ñÀý
    • Èĸ¸Áõ

Á¦7Àå °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå : ÀûÀÀÁõº°

  • ½ÃÀå ÇöȲ
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå : ÀûÀÀÁõº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå : ÀûÀÀÁõº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • °ñ´Ù°øÁõ
    • ±âŸ

Á¦8Àå °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ½ÃÀå ÇöȲ
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • º´¿ø ¹× Ŭ¸®´Ð
    • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ

Á¦9Àå °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå : Áö¿ªº° ºÐ¼®

  • ÁÖ¿ä »óÀ§ ±¹°¡
  • ÁÖ¿ä ½ÅÈï ±¹°¡
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¼¼°è ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
      • Á¦Ç°º°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ¿ëµµº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ÀûÀÀÁõº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ÃÖÁ¾ ¿ëµµº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
    • ij³ª´Ù
  • À¯·´ÀÇ °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå ÇöȲ
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå ÇöȲ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå ÇöȲ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Alphatec Holdings Inc
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ °¡¿ë¼º¿¡ µû¶ó ´Ù¸§)
      • Á¦Ç° °³¿ä
    • Medtronic Plc
    • IZI Medica Products LLC
    • Globul Medical Inc
    • Jhonson and Jhonson Pvt Ltd
    • Swawon Meditech Co., Ltd
    • Stryker Corporation
    • Merit Medicals Systems
    • Benvenue Medical Inc
    • Joline GmbH & Co. KG

Á¦11Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ±¤¾÷
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»ç °¡Á¤
ksm 23.11.28

Global Kyphoplasty Market is valued approximately USD 633.3 million in 2022 and is anticipated to grow with a healthy growth rate of more than 5.3% over the forecast period 2023-2030. Kyphoplasty is a medical procedure used to treat vertebral compression fractures, which are fractures in the bones of the spine (vertebrae) that result in a collapse or loss of height of the affected vertebra. These fractures can be caused by conditions such as osteoporosis, spinal tumors, or trauma. Kyphoplasty is primarily performed to relieve pain caused by vertebral compression fractures, stabilize the spine, and improve the patient's mobility and quality of life. The Kyphoplasty market is expanding because of factors such as the rising prevalence of osteoporosis worldwide and the rising Geriatric Population.

According to a study published in the journal Frontiers in Endocrinology in May 2022, 200 million women globally have osteoporosis. The incidence of hip fractures was predicted to rise by 240% for women and 310% for men globally by 2050. The same study stated that adults who already have one form of fracture are 50% to 100% more likely to get a different type of fracture, independent of the type and that practically all types of fractures increase in patients with low bone mineral density. This demonstrates that the most severe result of osteoporosis is a fracture and that the rising incidence of osteoporosis will ultimately spur market growth. Furthermore, according to the United Nations Department of Economics and Social 2022 research, which predicts that 771 million people would be 65 or older worldwide in 2022, the senior population will increase to 994 million by 2030 and 1.6 billion by 2050. Therefore, it is projected that the need for kyphoplasty would increase with the expanding senior population due to the loss of bone mass that occurs as part of aging in the elderly. In addition, increasing advancements in technology and increasing health expenditure are creating new opportunities for the market. However, the stringent regulatory framework and availability of alternative treatments stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Kyphoplasty Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, rising disease prevalence, rising favorable government reimbursement policies, and rising development of new products and healthcare expenditure in the region. Whereas, Asia Pacific is projected to grow at the fastest pace owing to factors such as a rising geriatric population, rising prevalence of various diseases, rising number of partnerships and coloration of product development activities, and rising healthcare expenditure in the region.

Major market player included in this report are:

  • Alphatec Holdings Inc
  • Medtronic Plc
  • IZI Medica Products LLC
  • Globul Medical Inc
  • Jhonson and Jhonson Pvt Ltd
  • Swawon Meditech Co., Ltd
  • Stryker Corporation
  • Merit Medicals Systems
  • Benvenue Medical Inc
  • Joline GmbH & Co. KG

Recent Developments in the Market:

  • In year 2022, IZI Medical Products developed Vertefix HV cement to meet the need for real-time flow visualization during cement injection for kyphoplasty and vertebroplasty surgeries. The corporation intended to enhance the instruments available to doctors for controlling cement flow during surgeries with this release.

Global Kyphoplasty Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Product, Application, Indication, End-use Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Balloon Catheters
  • Bone Access Devices
  • Cement Application Products
  • Bone Cement
  • Cement Mixing Systems
  • Instruments

By Application:

  • Vertebral Alignment Restoration
  • Spinal Fractures
  • Kyphosis

By Indication:

  • Osteoporosis
  • Others

By End-use:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1. Kyphoplasty Market, by Region, 2020-2030 (USD Million)
    • 1.2.2. Kyphoplasty Market, by Product, 2020-2030 (USD Million)
    • 1.2.3. Kyphoplasty Market, by Application, 2020-2030 (USD Million)
    • 1.2.4. Kyphoplasty Market, by Indication, 2020-2030 (USD Million)
    • 1.2.5. Kyphoplasty Market, by End-use, 2020-2030 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Kyphoplasty Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Kyphoplasty Market Dynamics

  • 3.1. Kyphoplasty Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising prevelance of osteoporosis
      • 3.1.1.2. Growing geriatric population
    • 3.1.2. Market Challenges
      • 3.1.2.1. Stringent regulatory framework
      • 3.1.2.2. Availability of alternative treatments
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing advancements in technology
      • 3.1.3.2. Increasing health expenditure

Chapter 4. Global Kyphoplasty Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Kyphoplasty Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Kyphoplasty Market by Product, Performance - Potential Analysis
  • 5.3. Global Kyphoplasty Market Estimates & Forecasts by Product 2020-2030 (USD Million)
  • 5.4. Kyphoplasty Market, Sub Segment Analysis
    • 5.4.1. Balloon Catheters
    • 5.4.2. Bone Access Devices
    • 5.4.3. Cement Application Products
    • 5.4.4. Bone Cement
    • 5.4.5. Cement Mixing Systems
    • 5.4.6. Instruments

Chapter 6. Global Kyphoplasty Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Kyphoplasty Market by Application, Performance - Potential Analysis
  • 6.3. Global Kyphoplasty Market Estimates & Forecasts by Application 2020-2030 (USD Million)
  • 6.4. Kyphoplasty Market, Sub Segment Analysis
    • 6.4.1. Vertebral Alignment Restoration
    • 6.4.2. Spinal Fractures
    • 6.4.3. Kyphosis

Chapter 7. Global Kyphoplasty Market, by Indication

  • 7.1. Market Snapshot
  • 7.2. Global Kyphoplasty Market by Indication, Performance - Potential Analysis
  • 7.3. Global Kyphoplasty Market Estimates & Forecasts by Indication 2020-2030 (USD Million)
  • 7.4. Kyphoplasty Market, Sub Segment Analysis
    • 7.4.1. Osteoporosis
    • 7.4.2. Others

Chapter 8. Global Kyphoplasty Market, by End-use

  • 8.1. Market Snapshot
  • 8.2. Global Kyphoplasty Market by End-use, Performance - Potential Analysis
  • 8.3. Global Kyphoplasty Market Estimates & Forecasts by End-use 2020-2030 (USD Million)
  • 8.4. Kyphoplasty Market, Sub Segment Analysis
    • 8.4.1. Hospitals & Clinics
    • 8.4.2. Ambulatory Surgical Centers

Chapter 9. Global Kyphoplasty Market, Regional Analysis

  • 9.1. Top Leading Countries
  • 9.2. Top Emerging Countries
  • 9.3. Kyphoplasty Market, Regional Market Snapshot
  • 9.4. North America Kyphoplasty Market
    • 9.4.1. U.S. Kyphoplasty Market
      • 9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 9.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 9.4.1.3. Indication breakdown estimates & forecasts, 2020-2030
      • 9.4.1.4. End-use breakdown estimates & forecasts, 2020-2030
    • 9.4.2. Canada Kyphoplasty Market
  • 9.5. Europe Kyphoplasty Market Snapshot
    • 9.5.1. U.K. Kyphoplasty Market
    • 9.5.2. Germany Kyphoplasty Market
    • 9.5.3. France Kyphoplasty Market
    • 9.5.4. Spain Kyphoplasty Market
    • 9.5.5. Italy Kyphoplasty Market
    • 9.5.6. Rest of Europe Kyphoplasty Market
  • 9.6. Asia-Pacific Kyphoplasty Market Snapshot
    • 9.6.1. China Kyphoplasty Market
    • 9.6.2. India Kyphoplasty Market
    • 9.6.3. Japan Kyphoplasty Market
    • 9.6.4. Australia Kyphoplasty Market
    • 9.6.5. South Korea Kyphoplasty Market
    • 9.6.6. Rest of Asia Pacific Kyphoplasty Market
  • 9.7. Latin America Kyphoplasty Market Snapshot
    • 9.7.1. Brazil Kyphoplasty Market
    • 9.7.2. Mexico Kyphoplasty Market
  • 9.8. Middle East & Africa Kyphoplasty Market
    • 9.8.1. Saudi Arabia Kyphoplasty Market
    • 9.8.2. South Africa Kyphoplasty Market
    • 9.8.3. Rest of Middle East & Africa Kyphoplasty Market

Chapter 10. Competitive Intelligence

  • 10.1. Key Company SWOT Analysis
    • 10.1.1. Company 1
    • 10.1.2. Company 2
    • 10.1.3. Company 3
  • 10.2. Top Market Strategies
  • 10.3. Company Profiles
    • 10.3.1. Alphatec Holdings Inc
      • 10.3.1.1. Key Information
      • 10.3.1.2. Overview
      • 10.3.1.3. Financial (Subject to Data Availability)
      • 10.3.1.4. Product Summary
      • 10.3.1.5. Recent Developments
    • 10.3.2. Medtronic Plc
    • 10.3.3. IZI Medica Products LLC
    • 10.3.4. Globul Medical Inc
    • 10.3.5. Jhonson and Jhonson Pvt Ltd
    • 10.3.6. Swawon Meditech Co., Ltd
    • 10.3.7. Stryker Corporation
    • 10.3.8. Merit Medicals Systems
    • 10.3.9. Benvenue Medical Inc
    • 10.3.10. Joline GmbH & Co. KG

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦